Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Roberto Taramelli"'
Autor:
Francesco Acquati, Lorenzo Mortara, Annarosaria De Vito, Denisa Baci, Adriana Albini, Marco Cippitelli, Roberto Taramelli, Douglas M. Noonan
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The link between cancer development or progression and immune system dysregulation has long been established. Virtually every cell type belonging to both the innate and adaptive immune system has been reported to be involved in a complex interplay th
Externí odkaz:
https://doaj.org/article/c127aa4935bc400b9dfff8c89e8893ac
Autor:
Francesco Acquati, Robert Hammer, Barbara Ercoli, Vincent Mooser, Ruixan Tao, Volker Rönicke, Alessandra Michalich, Giulia Chiesa, Roberto Taramelli, Helen H. Hobbs, Hans-Joachim Müller
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 6, Pp 994-1006 (1999)
The most important determinant of plasma levels of Lp[a] are sequence differences at the highly polymorphic apolipoprotein[a] (apo[a]) locus. To define the sequences that mediate the regulation of apo[a] expression, we cloned a 370 kb DNA fragment th
Externí odkaz:
https://doaj.org/article/78662c2c57a9468abaf6631d02769ce3
Autor:
Antonino Bruno, Douglas M. Noonan, Roberto Valli, Giovanni Porta, Roberto Taramelli, Lorenzo Mortara, Francesco Acquati
Publikováno v:
International Journal of Molecular Sciences. 23:9074
Ovarian cancer represents one of the most malignant gynecological cancers worldwide, with an overall 5-year survival rate, being locked in the 25–30% range in the last decade. Cancer immunotherapy is currently one of the most intensively investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33720fcc506c1238ef638b6821bb21b
https://doi.org/10.3390/ijms23169074
https://doi.org/10.3390/ijms23169074
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-4 (2018)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a879f82929d34ed576c020595d5c4eb
http://link.springer.com/article/10.1038/s41598-018-36408-x
http://link.springer.com/article/10.1038/s41598-018-36408-x
Autor:
Annarosaria, De Vito, Paola, Orecchia, Enrica, Balza, Daniele, Reverberi, Debora, Scaldaferri, Roberto, Taramelli, Douglas M, Noonan, Francesco, Acquati, Lorenzo, Mortara
Publikováno v:
Cancers
Human RNASET2 acts as a powerful oncosuppressor protein in in vivo xenograft-based murine models of human cancer. Secretion of RNASET2 in the tumor microenvironment seems involved in tumor suppression, following recruitment of M1-polarized macrophage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f2fa31560ca806c485af161c8843a67
https://pubmed.ncbi.nlm.nih.gov/32197460
https://pubmed.ncbi.nlm.nih.gov/32197460
Autor:
Raffaella Cinquetti, Laura Monti, Paola Pesce, Federico Caicci, Ileana Badi, Marina Campione, Roberto Taramelli, Michela Menegollo, Simonetta Ausoni, Francesco Acquati, Stefano Manzini, Beatrice Scellini, David Sacerdoti, Marco Busnelli, Simone Tiso, F. Dellera, Chiara Tesi, Corrado Poggesi, Annalisa Grimaldi, Daniele Bruno, Nicoletta Piroddi, Lucia Manni, Steven B. Bleyl, G.S. Ganzetti, Virginia Cora, Giulia Chiesa
AimsIncreased Ankyrin Repeat Domain 1 (ANKRD1) levels linked to gain of function mutations have been associated to total anomalous pulmonary venous return and adult cardiomyopathy occurrence in humans. The link between increased ANKRD1 level and card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222b037931a48c17af395b8d981a1758
https://hdl.handle.net/11383/2086490
https://hdl.handle.net/11383/2086490
Autor:
Cristina Riva, Francesca Roggiani, Roberto Valli, Delia Mezzanzanica, Giovanni Porta, Antonella Tomassetti, Roberto Taramelli, Francesco Acquati, Francesco Raspagliesi
Publikováno v:
Cancers
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 255 (2019)
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 255 (2019)
RNASET2 is an extracellular ribonuclease endowed with a marked antitumorigenic role in several carcinomas, independent from its catalytic activity. Besides its antitumorigenic role by the recruitment to the tumor mass of immune cells from the monocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840489726ee1c9bd88fc67ab071f319f
Autor:
Nicolò Baranzini, Marta Vanotti, Viviana Teresa Orlandi, Annalisa Grimaldi, Gianluca Tettamanti, Magda de Eguileor, Laura Monti, Debora Scaldaferri, Roberto Taramelli, Rossana Girardello, Francesco Acquati, Fabrizio Bolognese, Jacopo Vizioli
Recent studies demonstrated that allograft inflammatory factor-1 (AIF-1) and RNASET2 act as chemoattractants for macrophages and modulate the inflammatory processes in both vertebrates and invertebrates. The expression of these proteins significantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c388ba7b85da3463e79be293076b87a7
http://hdl.handle.net/11383/2074866
http://hdl.handle.net/11383/2074866
Autor:
Edoardo Pedrini, Marco Fabbri, Roberto Taramelli, Giovanna Turconi, Debora Scaldaferri, Marta Lualdi, Laura Monti, Francesco Acquati, Laura Gribaldo
Publikováno v:
International Journal of Oncology. 49:2637-2646
Ribonucleases (RNases) are hydrolytic enzymes endowed with the ability to either process or degrade ribonucleic acids. Among the many biological functions assigned to RNases, a growing attention has been recently devoted to the control of cancer grow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ce3041d7c3783ce5135ceb65bf8a88
https://doi.org/10.3892/ijo.2016.3763
https://doi.org/10.3892/ijo.2016.3763
Autor:
Daniele Reverberi, Annarosaria De Vito, Enrica Balza, Paola Orecchia, Roberto Taramelli, Francesco Acquati, Debora Scaldaferri, Lorenzo Mortara, Douglas M. Noonan
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 717 (2020)
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 717 (2020)
Human RNASET2 acts as a powerful oncosuppressor protein in in vivo xenograft-based murine models of human cancer. Secretion of RNASET2 in the tumor microenvironment seems involved in tumor suppression, following recruitment of M1-polarized macrophage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4448705290e8e57a311580f626509722
https://doi.org/10.3390/cancers12030717
https://doi.org/10.3390/cancers12030717